Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study

Malnutrition is associated with a greater risk of morbidity and mortality and lower tolerance to chemotherapy. Our purpose was to study the association between nutritional status and the efficiency and tolerance of immunotherapy in non-small cell lung cancer (NSCLC). Nutritional and oncological data...

Full description

Bibliographic Details
Main Authors: Manon Gouez, Lidia Delrieu, Carole Bouleuc, Nicolas Girard, Bruno Raynard, Timothée Marchal
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/14/3439
_version_ 1797407117474267136
author Manon Gouez
Lidia Delrieu
Carole Bouleuc
Nicolas Girard
Bruno Raynard
Timothée Marchal
author_facet Manon Gouez
Lidia Delrieu
Carole Bouleuc
Nicolas Girard
Bruno Raynard
Timothée Marchal
author_sort Manon Gouez
collection DOAJ
description Malnutrition is associated with a greater risk of morbidity and mortality and lower tolerance to chemotherapy. Our purpose was to study the association between nutritional status and the efficiency and tolerance of immunotherapy in non-small cell lung cancer (NSCLC). Nutritional and oncological data were reported at 2 months (M2) and 4 months (M4) after the initiation of immunotherapy (M0). The influence of nutritional status at M0 was estimated with the efficacy and toxicity of immunotherapy at M2 to M4. In total, 127 patients were included in the study, and nutritional status was estimated at M0 for 120 patients: 67% were not malnourished, 20% presented with moderate malnutrition, and 13% presented with severe malnutrition. There was no significant link between the nutritional status at M0 and the toxicity of immunotherapy at M2 and M4. However, severe malnutrition was significantly associated with treatment efficacy at M2 (<i>p</i> = 0.04) and with a lower survival rate with an HR (Hazard Ratio) = 2.32–95% C.I: 1.13–4.75 (<i>p</i> = 0.02). Furthermore, a monthly decrease of 1% of the weight had an HR = 1.17–95% C.I: 1.13–1.21 (<i>p</i> = 0.0001). Severe malnutrition and weight loss are independent factors associated with lower survival. Studies integrating the systemic detection of sarcopenia with a closer nutritional follow-up could highlight an improvement in survival.
first_indexed 2024-03-09T03:36:38Z
format Article
id doaj.art-9241f9e9c3574990ae80780c93469d49
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T03:36:38Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-9241f9e9c3574990ae80780c93469d492023-12-03T14:47:44ZengMDPI AGCancers2072-66942022-07-011414343910.3390/cancers14143439Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French StudyManon Gouez0Lidia Delrieu1Carole Bouleuc2Nicolas Girard3Bruno Raynard4Timothée Marchal5Department of Prevention Cancer Environment, Léon Bérard Cancer Centre, 69008 Lyon, FranceResidual Tumour & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, FranceDepartment of Supportive Care, Institut Curie, 75005 Paris, FranceInstitut Curie, Institut du Thorax Curie Montsouris, 75005 Paris, FranceDepartment of Supportive Care, Unité Transversale de Diététique et de Nutrition Centre Gustave-Roussy, 94800 Villejuif, FranceDepartment of Supportive Care, Institut Curie, 75005 Paris, FranceMalnutrition is associated with a greater risk of morbidity and mortality and lower tolerance to chemotherapy. Our purpose was to study the association between nutritional status and the efficiency and tolerance of immunotherapy in non-small cell lung cancer (NSCLC). Nutritional and oncological data were reported at 2 months (M2) and 4 months (M4) after the initiation of immunotherapy (M0). The influence of nutritional status at M0 was estimated with the efficacy and toxicity of immunotherapy at M2 to M4. In total, 127 patients were included in the study, and nutritional status was estimated at M0 for 120 patients: 67% were not malnourished, 20% presented with moderate malnutrition, and 13% presented with severe malnutrition. There was no significant link between the nutritional status at M0 and the toxicity of immunotherapy at M2 and M4. However, severe malnutrition was significantly associated with treatment efficacy at M2 (<i>p</i> = 0.04) and with a lower survival rate with an HR (Hazard Ratio) = 2.32–95% C.I: 1.13–4.75 (<i>p</i> = 0.02). Furthermore, a monthly decrease of 1% of the weight had an HR = 1.17–95% C.I: 1.13–1.21 (<i>p</i> = 0.0001). Severe malnutrition and weight loss are independent factors associated with lower survival. Studies integrating the systemic detection of sarcopenia with a closer nutritional follow-up could highlight an improvement in survival.https://www.mdpi.com/2072-6694/14/14/3439advanced cancerimmunotherapylung cancernutritional statussurvival
spellingShingle Manon Gouez
Lidia Delrieu
Carole Bouleuc
Nicolas Girard
Bruno Raynard
Timothée Marchal
Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study
Cancers
advanced cancer
immunotherapy
lung cancer
nutritional status
survival
title Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study
title_full Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study
title_fullStr Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study
title_full_unstemmed Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study
title_short Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study
title_sort association between nutritional status and treatment response and survival in patients treated with immunotherapy for lung cancer a retrospective french study
topic advanced cancer
immunotherapy
lung cancer
nutritional status
survival
url https://www.mdpi.com/2072-6694/14/14/3439
work_keys_str_mv AT manongouez associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy
AT lidiadelrieu associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy
AT carolebouleuc associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy
AT nicolasgirard associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy
AT brunoraynard associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy
AT timotheemarchal associationbetweennutritionalstatusandtreatmentresponseandsurvivalinpatientstreatedwithimmunotherapyforlungcanceraretrospectivefrenchstudy